Showing results (431-440 of 439) with videos related to
Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 439 results.
Nature Medicine|March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapyChristoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2025
FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular LymphomaMatthew J Maurer, Vit K Prochazka, Tarec Christoffer El-Galaly, et al.Cancer Discovery|January 27, 2017
The Genetic Basis of Hepatosplenic T-cell LymphomaMatthew McKinney, Andrea B Moffitt, Philippe Gaulard, et al.Cell|October 7, 2017
Genetic and Functional Drivers of Diffuse Large B Cell LymphomaAnupama Reddy, Jenny Zhang, Nicholas S Davis, et al.Cancer Research|May 9, 2018
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma SubtypesSophia S Wang, Mary Carrington, Sonja I Berndt, et al.Journal of the National Cancer Institute. Monographs|September 1, 2014
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Susan L Slager, James R Cerhan, et al.Human Molecular Genetics|March 25, 2016
Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypesMitchell J Machiela, Qing Lan, Susan L Slager, et al.Nature Genetics|September 29, 2014
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphomaJames R Cerhan, Sonja I Berndt, Joseph Vijai, et al.Pageof 44